Responses
Rheumatoid arthritis
Two-year cost-effectiveness of different COBRA-like intensive remission induction schemes in early rheumatoid arthritis: a piggyback study on the pragmatic randomised controlled CareRA trial
Compose a Response to This Article
Other responses
No responses have been published for this article.